At the iCMLf, our mission is to improve outcomes for people with CML worldwide. A key part of this is ensuring best-practice treatment reaches all those who need it. Since 2010, our programs in low- and middle-income countries have expanded access to CML education, professional networks, and expert discussions - leading to tangible improvements in CML management.
One of these key initiatives is the iCMLf Regional Discussions on CML, which are currently focused on Africa, Latin America, and South Asia. These discussions provide a dedicated space for physicians to engage with both local and international CML experts on region-specific challenges and advancements.
Each session is led by renowned CML specialists and fosters an inclusive, interactive environment. Physicians are encouraged to share cases, ask questions, and actively participate in discussions that address the most pressing issues in their region.
April 23: Dose reduction as a pathway to TFR AND Second or subsequent TFR attempts
May 21st: Choice of TKI in newly diagnosed CML patients AND 3rd line therapy - how do you choose the right thing at the right time?
July 2nd: Difficult CML cases from across the region
May 8th: Anticipating and managing acute TKI toxicity and adverse events AND Choosing third-line TKI therapy
June 26th: Dose reduction as a pathway to TFR AND Second or subsequent TFR attempts
September 11th: Molecular monitoring and aspects of mutational analysis that should be considered for CML management in 2025 Latin America AND Sanger vs NGS for mutation analysis: applicability in real-world Latin America
Our Regional Discussion Group Series for 2024 contained 12 meetings for Africa, South Asia, Latin America, and a special series for Pakistan. Download a full list with links to watch the recordings here: DOWNLOAD FULL LIST OF 2024 REGIONAL DISCUSSION GROUPS